FARINA, LUCIA

FARINA, LUCIA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Risultati 1 - 20 di 42 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin’s Lymphoma relapsed after high dose chemotherapy : a retrospective study based on donor availability 1-giu-2008 L. FarinaP. Corradini + Article (author) -
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome 1-gen-2007 P. CorradiniL. FarinaA. RambaldiA.M. GianniC. Tarella + Article (author) -
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 1-gen-2017 F. BarrettaA. MussettiF. OnidaL. FarinaA. RambaldiP. Corradini + Article (author) -
Allogeneic transplantation for Hodgkin's lymphoma 1-feb-2011 P. CorradiniL. Farina + Article (author) -
Allogeneic transplantation for lymphoma : long-term outcome 1-nov-2010 P. CorradiniL. Farina Article (author) -
Antibiotic prophylaxis before dental procedures can reduce ONJ incidence 1-gen-2007 L. FarinaP. Corradini + Article (author) -
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates 1-gen-2008 F. SpinaL. FarinaS. PivaP. Corradini + Article (author) -
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 1-gen-2006 C. Carlo-StellaA. GuidettiC. LavazzaL. FarinaA.M. GianniP. Corradini + Article (author) -
CD8-depleted donor lymphocyte infusions can boost immune reconstitution after haploidentical stem cell transplantation following reduced-intensity conditioning regimen 1-gen-2006 P. CorradiniA. RaganatoL. FarinaZORZAN, ELISABETTA + Article (author) -
CD8-depleted donor lymphocyte infusions can improve both T- and B-cell reconstitution after allogeneic stem cell transplantation from haploidentical family donors 1-dic-2008 A. RaganatoL. FarinaP. Corradini + Article (author) -
Current role of allogeneic stem cell transplantation in follicular lymphoma 1-mag-2007 L. FarinaP. Corradini Article (author) -
Current state of art for transplantation paradigms in peripheral T-cell lymphomas 1-ago-2013 L. FarinaP. Corradini + Article (author) -
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome 1-gen-2021 Guidetti, AnnaPennisi, MartinaFarina, LuciaCorradini, Paolo + Article (author) -
Efficacy and safety of cytarabine-based regimens for mobilization of peripheral blood stem cells in multiple myeloma 1-gen-2007 L. FarinaP. Corradini + Article (author) -
Haemato-oncology and burnout : an Italian survey 1-gen-2008 C. BressiS. ManentiM. PorcellanaL. FarinaG. Lambertenghi-DeliliersG. Invernizzi + Article (author) -
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 1-mag-2009 RAGANATO, ANNAA. VendraminL. FarinaF. SpinaC. Carlo StellaP. Corradini + Article (author) -
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation 1-giu-2009 L. FarinaF. SpinaMORELLI, MARAP. Corradini + Article (author) -
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 1-gen-2008 L. FarinaP. Corradini + Article (author) -
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 1-gen-2008 L. FarinaP. Corradini + Article (author) -
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 1-gen-2008 L. FarinaP. Corradini + Article (author) -